The decision to conduct clinical trials in a new region or country is not only a solution to the problems of regulatory support and obtaining research approval. When conducting a clinical trial, the organization faces many issues: from importing the study drug and exporting biological samples to the specifics of interacting with medical organizations, research centers and patient organizations. We provide comprehensive advice on all these issues.
